Atorvastatin Calcium
Product Images NDC 68071-4336

5 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4336). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

68071 4336 3 A86

68071 4336 3 A86
Packaging label for Atorvastatin Calcium 20mg tablets from NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets, each film-coated and oval white/off-white with engraving. The label includes instructions to take the medication every specified number of hours, the product number P1915030, and a warning to keep out of reach of children. Storage temperature is specified as 59-86°F, with additional information including lot number, NDC 68071-4336-3, manufacturer details, and a QR code.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing cumulative incidence (%) over 3.5 years comparing Atorvastatin and placebo groups. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value indicating statistical significance. The solid line represents Atorvastatin, and the dashed line represents placebo.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A Kaplan-Meier curve chart showing cumulative hazard percentage over time in years to the first primary endpoint through four years of follow-up. It compares Atorvastatin (solid line) with placebo (dashed line), illustrating the difference in cumulative hazard between the two groups.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over 5 years for Atorvastatin 10 mg and 80 mg doses. The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis represents subjects (%) experiencing the event. The graph includes a hazard ratio (HR) of 0.78 (0.69-0.89) with a p-value of 0.0002, indicating statistical comparison between the two doses.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium showing its molecular composition with calcium ions and atorvastatin molecules represented according to standard chemical notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.